EN DE
Watch MGI Tech Co. Ltd. A for free: we tell you when fair value or trend changes.
Data-driven stock valuation

MGI Tech Co. Ltd. A (688114) fair value: what the stock is really worth

As of Oct 23, 2026: fair value (intrinsic value) of MGI Tech Co. Ltd. A stock ¥6.72, price ¥62.52, upside -89.3%, quality 53 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare · CN

MT MGI Tech Co. Ltd. A logo Thin data Oct 24, 2026

MGI Tech Co. Ltd. A

688114 · SHG

Stretched ValuationStrong overvaluation with only moderate quality.

Our calculation puts a fair price 89% below what the stock costs today.

Low debt
Generates free cash flow
Quality 53/100
Insider activity 40/100
Fair value ¥6.72 · Strongly overvalued (−89.3%)
Weak Growth (revenue 5y +0.0 %/yr in CNY)
Loss-making · -7.1% net margin (TTM)
Trails peers (2/11)
Narrow moat 12/100 · thin data
Thin data
Structural break

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

¥140.06 ¥35.79 Fair Value ¥6.72 Sep 2022 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 24, 2026.

How to read this chart

49‑month range ¥35.79 – ¥140.06 · fair‑value band ¥6.30 – ¥7.50 · the ¥62.52 price screens above the ¥6.72 fair value. Dashed = 300-day average. As of Oct 24, 2026.

Follow MGI Tech Co. Ltd. A in your weekly email

Every Wednesday you see whether MGI Tech Co. Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally.

Show moreShow less

Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits multiplex immunofluorescence reagent staining sets, and bioinformatics analysis; lab automation products comprising sample pretreatment products, sample preparation platforms, and integrated testing platforms; novel products, including STOmics, cell omics, ultrasound, BIT, and sample storage products, as well as microneedling products.

MGI Tech Co., Ltd. was founded in 2016 and is headquartered in Shenzhen, China.

Stock analysis

MGI Tech Co. Ltd. A (688114) currently trades at ¥62.52, while our model-based Fair Value estimate is ¥6.72, 89.3% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of ¥9.35 per share, and 0 of the 10 models we run sit above the ¥62.52 price.

Bear case: the Multiples group reads lowest at ¥5.46, and 10 of the 10 models stay below the price. Data coverage for this calculation is low.

Scenario range: ¥6.30 (bear) to ¥7.50 (bull), the price of ¥62.52 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

MGI Tech Co. Ltd. A reported revenue of 2.8B CNY in FY2025 versus 3.9B CNY in FY2021, a compound −8.3%/yr. Reported net income was −222M CNY in FY2025.

Key figures

Market cap 26.0B CNY (≈ $3.9B) Mid · P/S ratio 9.99 · EPS (TTM) ¥−0.5100 · Dividend yield 0.1% · Net margin −7.1% · Return on equity −2.9% · Return on assets (EBIT) 1.3% · Operating margin −5.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 21% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 1% fair-value upside, at −89%, 688114 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (¥0.4700 to ¥11.24). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear ¥6.30 Fair Value ¥6.72 Bull ¥7.50
Price ¥62.52 · Upside -89.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ¥6.30 ¥6.72 ¥7.50 82
Growth DCF ¥6.35 ¥6.76 ¥7.45 80
5Y EBITDA Exit ¥8.86 ¥11.24 ¥14.41 77
All 10 models by family
DCF Models
FCF DCF ¥6.30 ¥6.72 ¥7.50 82
5Y Revenue Exit ¥5.93 ¥6.18 ¥6.54 74
5Y EBITDA Exit ¥8.86 ¥11.24 ¥14.41 77
10Y Revenue Exit ¥6.06 ¥6.25 ¥6.46 68
10Y EBITDA Exit ¥7.84 ¥9.37 ¥11.05 70
Dividend Discount
Gordon GGM ¥0.4300 ¥0.4700 ¥0.5300 69
DDM Multi-Stage ¥0.4300 ¥0.5400 ¥0.6900 67
Multiples
EV/EBITDA ¥3.40 ¥5.46 ¥7.51 66
Asset-Based
NCAV (Graham) ¥6.17 ¥9.35 ¥11.68 55
Growth DCF
Growth DCF ¥6.35 ¥6.76 ¥7.45 80

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 11
How much profit the company makes from its sales and capital
Quality Growth 50
Are margins and returns getting better?
Cashflow 19
Do the profits arrive as real cash?
Financial strength 97
Debt, balance sheet and risk of trouble
Investment 91
Does it invest with discipline instead of growing at any price?
Low Volatility 53
How calm the share price moves, does not count
Momentum 57
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 35
Distance to the 52-week high, does not count
New shares 81
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 23/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−7.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.0%
Start year 2020 (pandemic)
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
13.1% (2020) → −5.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

688114 screens overvalued: fair value 89% below the price. Compare with Abbott Laboratories, →

Compare MGI Tech Co. Ltd. A with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 325 stocks

Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 53 · Above median
Fair Value upside −89.3% · Bottom 25%
Profitability
Return on assets −2.2% · Below median
Net margin (12 months) −7.1% · Below median
Operating margin (12 months) −5.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 14.8% · Above median
Dividend yield (12 months) 0.1% · Bottom 25%
Balance sheet
Debt / equity 0.08× · Above median

Valuation Multiplesvs Medical Devices median · lower = cheaper

P/B 3.41× · Priciest 25%
P/S (12 months) 8.69× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 8
FUTURE (revenue growth)74 · sector 32
PAST (return on equity)0 · sector 16
HEALTH (low debt)96 · sector 98
DIVIDEND (yield)1 · sector 36

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "MGI Tech Co. Ltd. A Fair Value". https://www.fairvalue-calculator.com/stock/688114

Frequently asked questions

Is MGI Tech Co. Ltd. A (688114) overvalued or undervalued?
As of Oct 24, 2026, our model estimates a fair value of ¥6.72 versus a price of ¥62.52, about −89% upside (overvalued).
What is the fair value of 688114?
Our model-based fair value for MGI Tech Co. Ltd. A is ¥6.72 (as of Oct 24, 2026), built from audited fundamentals. The current price: ¥62.52.
What is the quality score of 688114?
MGI Tech Co. Ltd. A has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MGI Tech Co. Ltd. A (688114)?
Our model-based price target is the fair value of ¥6.72 (as of Oct 24, 2026) from 10 valuation models. Cautious scenario ¥6.30, optimistic scenario ¥7.50. It is a calculation from audited fundamentals, not an analyst target.
What is the MGI Tech Co. Ltd. A stock forecast for 2026?
Our models put fair value at ¥6.72, about −89% upside versus a price of ¥62.52 (overvalued). Cautious scenario ¥6.30, optimistic scenario ¥7.50. The calculation is refreshed regularly with new filings.
What is the revenue of MGI Tech Co. Ltd. A (688114)?
MGI Tech Co. Ltd. A reported trailing-twelve-month revenue of about 3.0B CNY (latest available figure, as of Oct 24, 2026).
Does MGI Tech Co. Ltd. A pay a dividend?
MGI Tech Co. Ltd. A currently shows a dividend yield of 0.07% relative to its recent price (as of Oct 24, 2026).
What is the intrinsic value of MGI Tech Co. Ltd. A (688114)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MGI Tech Co. Ltd. A it is ¥6.72 per share (as of Oct 24, 2026), against a price of ¥62.52. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is MGI Tech Co. Ltd. A stock overvalued or undervalued in 2026?
As of Oct 24, 2026, 688114 trades above its calculated fair value: price ¥62.52, fair value ¥6.72, a gap of about −89% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 688114?
No. The price is what the market pays today (¥62.52); the fair value is what the company's own numbers justify (¥6.72). For MGI Tech Co. Ltd. A the two are ¥55.80 per share apart. That gap is exactly why we show both numbers side by side.
How much is MGI Tech Co. Ltd. A worth?
The market values MGI Tech Co. Ltd. A at about 26.0B CNY (market capitalisation, as of Oct 24, 2026). Per share that is ¥62.52; our models calculate a fair value of ¥6.72 per share.
What do the bullish and bearish scenarios say about 688114?
Our models span a range for MGI Tech Co. Ltd. A: cautious scenario ¥6.30, base ¥6.72, optimistic ¥7.50 per share (as of Oct 24, 2026, price ¥62.52). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of MGI Tech Co. Ltd. A (688114)?
Balance-sheet figures for MGI Tech Co. Ltd. A (as of Oct 24, 2026): return on equity −2.9%, debt of 0.08 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is 688114 from its 52-week high?
MGI Tech Co. Ltd. A trades at ¥62.52, about 21% below its 52-week high of ¥78.78 and 36% above the low of ¥45.89 (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of ¥6.72 is for.
Which stocks are comparable to MGI Tech Co. Ltd. A?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MGI Tech Co. Ltd. A stock attractive at the current price?
The data as of Oct 24, 2026: price ¥62.52, calculated fair value ¥6.72 (−89%), Quality Score 53/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 688114 calculated?
We run MGI Tech Co. Ltd. A through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥6.72, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3 % above its aggregate fair value. MGI Tech Co. Ltd. A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MGI Tech Co. Ltd. A (688114)?
The closing price on Oct 23, 2026 was ¥62.52. Our model-based fair value is ¥6.72, about −89% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MGI Tech Co. Ltd. A right now?
The price sits above even our optimistic bull case (¥7.50). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of MGI Tech Co. Ltd. A

How large is the market capitalisation of MGI Tech Co. Ltd. A (688114)?
The market capitalisation of MGI Tech Co. Ltd. A is 26.0B CNY (≈ $3.9B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MGI Tech Co. Ltd. A (688114)?
The price-to-sales ratio of MGI Tech Co. Ltd. A is 9.99 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MGI Tech Co. Ltd. A (688114)?
Earnings per share at MGI Tech Co. Ltd. A are ¥−0.5100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of MGI Tech Co. Ltd. A (688114)?
The dividend yield of MGI Tech Co. Ltd. A is 0.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of MGI Tech Co. Ltd. A (688114)?
The net margin of MGI Tech Co. Ltd. A is −7.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MGI Tech Co. Ltd. A (688114)?
The return on equity (ROE) of MGI Tech Co. Ltd. A is −2.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MGI Tech Co. Ltd. A (688114)?
On an EBIT basis the return on assets of MGI Tech Co. Ltd. A is 1.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MGI Tech Co. Ltd. A (688114)?
The operating margin of MGI Tech Co. Ltd. A is −5.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at MGI Tech Co. Ltd. A (688114)?
Revenue at MGI Tech Co. Ltd. A is growing +14.8% versus a year earlier (3y avg −13.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at MGI Tech Co. Ltd. A (688114)?
Earnings per share at MGI Tech Co. Ltd. A are growing +31.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does MGI Tech Co. Ltd. A (688114) generate?
The free cash flow of MGI Tech Co. Ltd. A is 24.5M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does MGI Tech Co. Ltd. A (688114) carry?
The net debt of MGI Tech Co. Ltd. A is 1.1B CNY (fiscal year 2019, ≈ 46.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch MGI Tech Co. Ltd. A in the live analysis

One click puts MGI Tech Co. Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.